Clifford Chance advises on PW Medtech's HK$1.2 billion listing
Clifford Chance has advised Morgan Stanley as the sole underwriter and bookrunner of the global offering of PW Medtech's HK$1.2 billion (approx. US$155 million) listing on the Main Board of the Stock Exchange of Hong Kong.
A total of 400 million shares were on offer and priced at HK$3.18 each. The offering was 19.33 times oversubscribed.
Partner Tim Wang who led on this transaction, said, "I'm pleased to have worked on this listing, which was very well received by the market."